BR9609744A - Derivados de pirrolidina tendo atividade inibitória de fosfolipase a2 - Google Patents
Derivados de pirrolidina tendo atividade inibitória de fosfolipase a2Info
- Publication number
- BR9609744A BR9609744A BR9609744A BR9609744A BR9609744A BR 9609744 A BR9609744 A BR 9609744A BR 9609744 A BR9609744 A BR 9609744A BR 9609744 A BR9609744 A BR 9609744A BR 9609744 A BR9609744 A BR 9609744A
- Authority
- BR
- Brazil
- Prior art keywords
- inhibitory activity
- pyrrolidine derivatives
- phospholipase inhibitory
- phospholipase
- inhibiting
- Prior art date
Links
- 230000002401 inhibitory effect Effects 0.000 title abstract 3
- ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 title 1
- 102000015439 Phospholipases Human genes 0.000 title 1
- 108010064785 Phospholipases Proteins 0.000 title 1
- 150000003235 pyrrolidines Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000001086 cytosolic effect Effects 0.000 abstract 1
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 abstract 1
- 229960002986 dinoprostone Drugs 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Detergent Compositions (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP19464895 | 1995-07-31 | ||
| PCT/JP1996/002079 WO1997005135A1 (en) | 1995-07-31 | 1996-07-25 | Pyrrolidine derivatives having phospholipase a2 inhibitory activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9609744A true BR9609744A (pt) | 1999-03-02 |
Family
ID=16328012
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9609744A BR9609744A (pt) | 1995-07-31 | 1996-07-25 | Derivados de pirrolidina tendo atividade inibitória de fosfolipase a2 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5955616A (pt) |
| EP (1) | EP0848004B1 (pt) |
| JP (1) | JP3923079B2 (pt) |
| KR (1) | KR100429950B1 (pt) |
| CN (1) | CN1064682C (pt) |
| AT (1) | ATE236154T1 (pt) |
| AU (1) | AU707537B2 (pt) |
| BR (1) | BR9609744A (pt) |
| CA (1) | CA2227829A1 (pt) |
| DE (1) | DE69627164T2 (pt) |
| DK (1) | DK0848004T3 (pt) |
| ES (1) | ES2196163T3 (pt) |
| MX (1) | MX9800804A (pt) |
| PT (1) | PT848004E (pt) |
| TR (1) | TR199800157T1 (pt) |
| WO (1) | WO1997005135A1 (pt) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9515975D0 (en) | 1995-08-04 | 1995-10-04 | Zeneca Ltd | Chemical compounds |
| US5889025A (en) * | 1996-05-06 | 1999-03-30 | Reddy's Research Foundation | Antidiabetic compounds having hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them |
| WO1998007692A1 (en) | 1996-08-17 | 1998-02-26 | Zeneca Limited | 3-mercaptopyrrolidines as farnesyl protein transferase inhibitors |
| BR9712792A (pt) * | 1996-08-28 | 1999-12-14 | Procter & Gamble | Inibidores de metaloprotease bidentada. |
| TW577875B (en) * | 1997-01-31 | 2004-03-01 | Shionogi & Co | Pyrrolidine derivatives with inhibitory activity for phospholipase A2 |
| CA2309331A1 (en) * | 1997-11-12 | 1999-05-20 | Institute Of Medicinal Molecular Design, Inc. | Agent acting on retinoid receptor |
| HUP0100156A3 (en) * | 1998-02-25 | 2002-12-28 | Genetics Inst Inc Cambridge | Indole derivatives as inhibitors of phospholipase a2 and use of them for producing pharmaceutical compositions |
| EP1109808A1 (en) * | 1999-07-01 | 2001-06-27 | Geron Corporation | Substituted indole compounds and their use for the treatment of cancer |
| AU6023300A (en) * | 1999-07-26 | 2001-02-13 | Shionogi & Co., Ltd. | Drug compositions exhibiting thrombopoietin agonism |
| CA2388479A1 (en) * | 1999-10-22 | 2001-05-03 | Shionogi & Co., Ltd. | Preventives or remedies for arrhythmia |
| GB9930318D0 (en) | 1999-12-22 | 2000-02-09 | Zeneca Ltd | Novel compounds |
| GB9930317D0 (en) | 1999-12-22 | 2000-02-09 | Zeneca Ltd | Novel compounds |
| AU4456601A (en) * | 2000-03-28 | 2001-10-08 | Nippon Soda Co., Ltd. | Oxa(thia)zolidine derivative and anti-inflammatory drug |
| US6784199B2 (en) * | 2000-09-21 | 2004-08-31 | Aryx Therapeutics | Isoxazolidine compounds useful in the treatment of diabetes, hyperlipidemia, and atherosclerosis in mammals |
| US6768008B2 (en) | 2000-04-24 | 2004-07-27 | Aryx Therapeutics | Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis |
| JP2003531200A (ja) * | 2000-04-24 | 2003-10-21 | アリックス セラピューティクス | 糖尿病、高脂血症、高コレステロール血症、およびアテローム性動脈硬化症の治療のための材料と方法 |
| US6958355B2 (en) | 2000-04-24 | 2005-10-25 | Aryx Therapeutics, Inc. | Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis |
| US6680387B2 (en) * | 2000-04-24 | 2004-01-20 | Aryx Therapeutics | Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis |
| US6492396B2 (en) * | 2000-05-16 | 2002-12-10 | Cephalon, Inc. | Substituted thioacetamides |
| US6670358B2 (en) * | 2000-05-16 | 2003-12-30 | Cephalon, Inc. | Substituted thioacetamides |
| MXPA03000504A (es) * | 2000-07-19 | 2003-06-24 | Hoffmann La Roche | Derivados de pirimidina. |
| CN1516696A (zh) * | 2001-01-26 | 2004-07-28 | 盐野义制药株式会社 | 对血小板生成素受体具有激动作用的卤素化合物 |
| US20060047000A1 (en) * | 2001-04-24 | 2006-03-02 | Aryx Therapeutics, Inc. | Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis |
| US7189751B2 (en) * | 2001-06-25 | 2007-03-13 | Nippon Soda Co., Ltd. | Oxa(thia)zolidine compounds, process for preparation thereof and anti-inflammatory agents |
| FR2833261B1 (fr) * | 2001-12-06 | 2004-07-02 | Yang Ji Chemical Company Ltd | Nouveaux composes inhibiteurs specifiques de la phospholipase a2 secretee non pancreatique humaine du groupe ii |
| AUPS282602A0 (en) | 2002-06-07 | 2002-06-27 | Garvan Institute Of Medical Research | Method of inhibiting cell proliferation |
| ES2315566T3 (es) * | 2002-11-22 | 2009-04-01 | Smithkline Beecham Corporation | Tiazolidin-4-onas para inhibir proteinas hyak3. |
| KR100843526B1 (ko) | 2004-02-27 | 2008-07-03 | 에프. 호프만-라 로슈 아게 | 피라졸의 접합 유도체 |
| DE102004014945A1 (de) * | 2004-03-26 | 2005-10-13 | Merck Patent Gmbh | Prolinylderivate |
| US20060293374A1 (en) * | 2005-06-24 | 2006-12-28 | Beers Scott A | Substituted isothiazolones |
| MX2011003991A (es) * | 2008-10-17 | 2011-06-24 | Exelixis Inc | Antagonistas del receptor esfingosina-1-fosfato. |
| EP3520860A1 (en) * | 2011-05-26 | 2019-08-07 | Indiana University Research & Technology Corporation | Quinone compounds for treating ape1 mediated diseases |
| US9181279B2 (en) * | 2011-07-04 | 2015-11-10 | Rottapharm Biotech S.R.L. | Cyclic amine derivatives as EP4 receptor antagonists |
| CA3224494A1 (en) | 2021-07-09 | 2023-01-12 | Koen Vandyck | Anti-viral compounds |
| WO2023043816A1 (en) | 2021-09-17 | 2023-03-23 | Aligos Therapeutics, Inc. | Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL57415A (en) * | 1978-05-30 | 1984-08-31 | Smith Kline French Lab | Nitropyrrole compounds,process for preparing them and pharmaceutical compositions containing them |
| JPS6184094A (ja) * | 1984-10-01 | 1986-04-28 | 日本電気株式会社 | 多層プリント配線板の検査用パタ−ン |
| JPS6212776A (ja) * | 1985-07-10 | 1987-01-21 | Taiho Yakuhin Kogyo Kk | ロ−ダニン誘導体 |
| US5130379A (en) * | 1988-03-08 | 1992-07-14 | Pfizer Inc. | Hypoglycemic thiazolidinedione derivatives |
| GB9025987D0 (en) * | 1990-11-29 | 1991-01-16 | Ilford Ltd | Merocyanine dyes |
| FR2680512B1 (fr) * | 1991-08-20 | 1995-01-20 | Adir | Nouveaux derives de 2,4-thiazolidinedione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| CZ281763B6 (cs) * | 1992-04-07 | 1997-01-15 | Pfizer Inc. | Indolové deriváty představující 5-HT1 agonisty, způsob jejich přípravy, farmaceutické prostředky obsahující tyto látky, jejich použití a meziprodukty postupu přípravy |
| GB9216962D0 (en) * | 1992-08-11 | 1992-09-23 | Erba Carlo Spa | Therapeutically active naphthalenesulfonic-pyrrolecarboxamido derivatives |
| AU4444393A (en) * | 1992-09-01 | 1994-03-10 | Zeneca Limited | Pyrrolidine derivatives |
| WO1994022857A1 (fr) * | 1993-04-07 | 1994-10-13 | Taiho Pharmaceutical Co., Ltd. | Derive de thiazolidine et composition pharmaceutique contenant ce derive |
| DE4317320A1 (de) * | 1993-05-25 | 1994-12-01 | Boehringer Mannheim Gmbh | Neue Thiazolidindione und diese enthaltende Arzneimittel |
| CN1115576A (zh) * | 1993-10-15 | 1996-01-24 | 盐野义制药株式会社 | 具有细胞浆磷脂酶a2抑制活性的噁唑啉酮衍生物 |
| JPH07138258A (ja) * | 1993-11-16 | 1995-05-30 | Taiho Yakuhin Kogyo Kk | チアゾリジンジオン誘導体又はその塩 |
| US5519134A (en) * | 1994-01-11 | 1996-05-21 | Isis Pharmaceuticals, Inc. | Pyrrolidine-containing monomers and oligomers |
-
1996
- 1996-07-25 US US09/011,404 patent/US5955616A/en not_active Expired - Fee Related
- 1996-07-25 AT AT96925076T patent/ATE236154T1/de not_active IP Right Cessation
- 1996-07-25 DK DK96925076T patent/DK0848004T3/da active
- 1996-07-25 PT PT96925076T patent/PT848004E/pt unknown
- 1996-07-25 DE DE69627164T patent/DE69627164T2/de not_active Expired - Fee Related
- 1996-07-25 KR KR10-1998-0700706A patent/KR100429950B1/ko not_active Expired - Fee Related
- 1996-07-25 TR TR1998/00157T patent/TR199800157T1/xx unknown
- 1996-07-25 JP JP50745397A patent/JP3923079B2/ja not_active Expired - Fee Related
- 1996-07-25 AU AU65308/96A patent/AU707537B2/en not_active Ceased
- 1996-07-25 CN CN96197208A patent/CN1064682C/zh not_active Expired - Fee Related
- 1996-07-25 EP EP96925076A patent/EP0848004B1/en not_active Expired - Lifetime
- 1996-07-25 BR BR9609744A patent/BR9609744A/pt not_active Application Discontinuation
- 1996-07-25 ES ES96925076T patent/ES2196163T3/es not_active Expired - Lifetime
- 1996-07-25 CA CA002227829A patent/CA2227829A1/en not_active Abandoned
- 1996-07-25 WO PCT/JP1996/002079 patent/WO1997005135A1/ja not_active Ceased
-
1998
- 1998-01-28 MX MX9800804A patent/MX9800804A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP3923079B2 (ja) | 2007-05-30 |
| CN1064682C (zh) | 2001-04-18 |
| DE69627164D1 (de) | 2003-05-08 |
| DE69627164T2 (de) | 2004-01-29 |
| MX9800804A (es) | 1998-07-31 |
| KR19990036041A (ko) | 1999-05-25 |
| EP0848004A1 (en) | 1998-06-17 |
| CN1197458A (zh) | 1998-10-28 |
| HK1016598A1 (en) | 1999-11-05 |
| KR100429950B1 (ko) | 2004-06-16 |
| EP0848004B1 (en) | 2003-04-02 |
| US5955616A (en) | 1999-09-21 |
| TR199800157T1 (xx) | 1998-06-22 |
| DK0848004T3 (da) | 2003-07-21 |
| AU6530896A (en) | 1997-02-26 |
| ES2196163T3 (es) | 2003-12-16 |
| ATE236154T1 (de) | 2003-04-15 |
| CA2227829A1 (en) | 1997-02-13 |
| PT848004E (pt) | 2003-07-31 |
| WO1997005135A1 (en) | 1997-02-13 |
| EP0848004A4 (en) | 1999-11-17 |
| AU707537B2 (en) | 1999-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9609744A (pt) | Derivados de pirrolidina tendo atividade inibitória de fosfolipase a2 | |
| NO950297D0 (no) | Prolinamidderivater | |
| AU2002211216A1 (en) | Substituted aminopropoxyaryl derivatives useful as agonists for lxr | |
| DK0976748T3 (da) | Pyrrolidinderivater med phospholispase A2-hæmmende aktivitet | |
| PT1043310E (pt) | Derivados de bifenilamidina | |
| PT882728E (pt) | Derivados de 1-metilcarbapenem | |
| FI952420A0 (fi) | Glukopyranosidibentsotiofeenit | |
| EP1026162A4 (en) | ANTI-RHUMATISMAL AGENT | |
| ES2196174T3 (es) | `derivados de sesquiterpeno de actividad antiviral. | |
| ATE176242T1 (de) | Uck14-verbindungen | |
| NO981093L (no) | 2-£2£(2-hydroksyetyl)amino|etyl|-5-££2-metylamino)etyl|amino|-indazolo£4,3-gh|isokinolin-6(2H)-on som antitumor middel | |
| ATE166058T1 (de) | Neue verbindung, leustroducsin h, ihre herstellung und therapeutische verwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PRESENTE PEDIDO COM BASE NOS ARTIGO 24 E 25, DA LEI 9279 DE 14/05/1996 |
|
| B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
| B25A | Requested transfer of rights approved |
Owner name: ANTHERA PHARMACEUTICALS, INC. (US) Free format text: TRANSFERIDO DE: SHIONOGI AND CO., LTD. |
|
| B11D | Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time |